Harvard Brain Tissue Resource Center

Migration, Crosslink

📖

Harvard Brain Tissue Resource Center

active

wiki page Created: 2026-04-02T07:20:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-harvard-brain-tissue-r

📖 Wiki Page

institution1254 wordssynced 2026-04-02

Overview

flowchart TD institutions_harvard_brain_tis["Harvard Brain Tissue Resource Center"] style institutions_harvard_brain_tis fill:#4fc3f7,stroke:#333,color:#000 institutions_harvard_0["Mission"] institutions_harvard_brain_tis -->|"includes"| institutions_harvard_0 style institutions_harvard_0 fill:#81c784,stroke:#333,color:#000 institutions_harvard_1["Collection Focus"] institutions_harvard_brain_tis -->|"includes"| institutions_harvard_1 style institutions_harvard_1 fill:#ef5350,stroke:#333,color:#000 institutions_harvard_2["Neurodegenerative Disease Collection"] institutions_harvard_brain_tis -->|"includes"| institutions_harvard_2 style institutions_harvard_2 fill:#ffd54f,stroke:#333,color:#000 institutions_harvard_3["Research Contributions"] institutions_harvard_brain_tis -->|"includes"| institutions_harvard_3 style institutions_harvard_3 fill:#ce93d8,stroke:#333,color:#000 institutions_harvard_4["Notable Discoveries"] institutions_harvard_brain_tis -->|"includes"| institutions_harvard_4 style institutions_harvard_4 fill:#4fc3f7,stroke:#333,color:#000 institutions_harvard_5["Collection Protocols"] institutions_harvard_brain_tis -->|"includes"| institutions_harvard_5 style institutions_harvard_5 fill:#81c784,stroke:#333,color:#000

...

Overview

Mermaid diagram (expand to render)

The Harvard Brain Tissue Resource Center (HBTRC), formerly known as the Harvard Brain Bank, is one of the United States' premier brain tissue repositories for neurodegenerative and psychiatric research. Located at McLean Hospital in Belmont, Massachusetts, the HBTRC is funded by the National Institute of Mental Health (NIMH) and provides postmortem brain tissue to qualified researchers worldwide.

Founded in 1986, the HBTRC has served as a critical resource for the neuroscience community, supporting over 3,000 research projects and distributing more than 50,000 tissue samples to investigators globally. The center maintains rigorous quality control standards and comprehensive documentation for all specimens, making it an invaluable resource for understanding the neurobiological basis of brain disorders.

Mission

The HBTRC's mission is to advance the understanding of psychiatric and neurological disorders by:

Collecting and preserving high-quality postmortem brain tissue
Supporting research on the neurobiological basis of brain disorders
Maintaining detailed clinical and demographic information
Facilitating collaboration between basic and clinical researchers
Providing educational resources on brain banking and neuropathology

Collection Focus

The HBTRC maintains one of the largest brain tissue collections in the world:

| Category | Focus Areas |
|----------|-------------|
| Neuropsychiatric | Schizophrenia, bipolar disorder, depression |
| Neurodegenerative | Alzheimer's disease, Parkinson's disease, ALS |
| Developmental | Autism, intellectual disabilities |
| Normal | Age-matched controls |

Neurodegenerative Disease Collection

The center's neurodegenerative disease collection includes:

Alzheimer's Disease: Over 400 cases with confirmed clinical and neuropathological diagnosis
Parkinson's Disease: More than 200 cases with Lewy body pathology
Amyotrophic Lateral Sclerosis (ALS): Approximately 150 cases with TDP-43 pathology
Frontotemporal Dementia: Cases with tau, TDP-43, and FUS pathology
Lewy Body Dementia: Cases with cortical and brainstem Lewy bodies
Vascular Dementia: Cases with significant cerebrovascular pathology

Each case includes detailed clinical information, including:

Comprehensive neuropsychological testing results
Medical history and medication records
Family history of neurological disease
Braak staging for neurofibrillary tangles
Thal phase for amyloid deposition
CERAD plaque scores

Research Contributions

The HBTRC has supported thousands of research projects:

Neuroimaging studies: Validating PET ligands for amyloid and tau imaging

Genetic studies: GWAS and whole-exome sequencing projects identifying disease risk variants

Protein analysis: Biomarker discovery and validation studies

Cellular studies: Neuropathology investigations of disease mechanisms

Gene expression studies: Transcriptomic and epigenomic analyses

Stem cell research: Induced pluripotent stem cell derivation for disease modeling

Notable Discoveries

Research using HBTRC tissue has contributed to numerous landmark discoveries:

Validation of amyloid PET ligands (Florbetapir, Florbetaben, Flortaucipir)
Identification of novel Alzheimer's disease risk genes (PLD3, TREM2)
Characterization of tau propagation mechanisms
Discovery of TDP-43 pathology in ALS and frontotemporal dementia
Understanding of alpha-synuclein Lewy body formation

Collection Protocols

The HBTRC employs standardized collection protocols to ensure tissue quality:

Brain Retrieval

Rapid postmortem interval (average <12 hours)
Systematic hemisphere dissection
Flash-freezing of tissue blocks in liquid nitrogen
Paraffin embedding for histological studies

Quality Assurance

Regular monitoring of RNA integrity numbers (RIN)
Neuropathological confirmation by board-certified neuropathologists
Standardized fixation protocols for immunostaining
Inventory tracking with complete case documentation

Access Procedures

Researchers can access HBTRC tissue through:

Application submission describing research objectives

Scientific review by external committee

Institutional IRB approval

Material transfer agreement

Tissue distribution and shipping

Application Requirements

Detailed research proposal
Funding confirmation
Laboratory capabilities for tissue processing
IRB approval documentation
CV and publication record

Collaborations and Partnerships

The HBTRC maintains active collaborations with:

NIH Neurobiology of Disease Brain Banks Consortium
Alzheimer's Disease Neuroimaging Initiative (ADNI)
Parkinson's Progression Markers Initiative (PPMI)
National Center for Advancing Translational Sciences (NCATS)
International Brain Bank Coordinating Committee

Training Programs

The center offers training opportunities for researchers:

Brain bank operation and management
Neuropathological assessment techniques
Tissue preparation for various applications
Quality control and data management

Statistics and Impact

The HBTRC by the numbers:

Over 3,000 brains in collection
More than 50,000 tissue samples distributed
500+ active research projects annually
200+ collaborating institutions worldwide
1,000+ peer-reviewed publications utilizing HBTRC tissue

Governance and Funding

The HBTRC is supported by:

National Institute of Mental Health (NIMH)
National Institute on Aging (NIA)
Private foundation grants
Corporate partnerships

The center is governed by a scientific advisory board with representatives from major research institutions, including Harvard Medical School, Massachusetts General Hospital, and the Broad Institute. Regular peer review ensures that the center maintains the highest standards of quality and scientific integrity.

Quality Metrics

The HBTRC maintains rigorous quality metrics for all tissue samples:

Postmortem Interval (PMI): Average <12 hours, with target <6 hours for optimal molecular studies
Tissue Quality: RNA integrity numbers (RIN) >7.0 for 95% of frozen specimens
Documentation: Complete clinical records for 100% of cases
Neuropathology: Comprehensive assessment by board-certified neuropathologists
Storage: -80°C frozen storage with continuous temperature monitoring
Traceability: Complete chain-of-custody documentation for all samples

Sample Types Available

Researchers can request various tissue preparations:

Fresh frozen: Unfixed, flash-frozen tissue for molecular studies
Formalin-fixed paraffin-embedded (FFPE): Tissue blocks and sections for histology
Fixed frozen: Cryoprotected tissue for immunohistochemistry
Isolated nuclei: Fresh nuclei for single-cell sequencing
RNA/DNA: Extracted nucleic acids from characterized cases
Plasma/CSF: Paired cerebrospinal fluid and plasma samples

Future Directions

The HBTRC is implementing several initiatives to enhance its contribution to neurodegenerative disease research:

Enhanced Clinical Characterization: Integrating longitudinal clinical data from clinicaltrials.gov and biomarker studies

Multi-omics Integration: Adding proteomic and metabolomic data to existing genomic resources

Stem Cell Repository: Creating a collection of induced pluripotent stem cell lines from well-characterized donors

Data Sharing Portal: Developing a public database for tissue availability and case metadata

Standardization Efforts: Promoting harmonization of brain bank protocols internationally

External Links

[HBTRC Website](https://www.brainbank.mclean.org)
[NIH NIMH](https://www.nimh.nih.gov)
[McLean Hospital](https://www.mcleanhospital.org)

References

[HBTRC Annual Report](https://www.brainbank.mclean.org)

[Braak H et al, Staging of brain pathology related to sporadic Parkinson's disease (2003)](https://pubmed.ncbi.nlm.nih.gov/12584368/)

[Jellinger KA et al, Staging of the pathology of Parkinson's disease (2004)](https://pubmed.ncbi.nlm.nih.gov/15567490/)

[Beach TG et al, Unified staging system for Lewy body disorders (2009)](https://pubmed.ncbi.nlm.nih.gov/19332113/)

[Hyman BT et al, National Institute on Aging-Alzheimer's Association guidelines (2012)](https://pubmed.ncbi.nlm.nih.gov/22436740/)

[Montine TJ et al, NIA-AA guidelines for neuropathologic assessment (2012)](https://pubmed.ncbi.nlm.nih.gov/22436744/)

[Vonsattel JPG et al, Neuropathology of Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32060967/)

[Dickson DW et al, Neuropathology of Alzheimer's disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29538653/)

[ Thal DR et al, Phases of Aβ-deposition in the human brain (2002)](https://pubmed.ncbi.nlm.nih.gov/12393245/)

[Alafuzoff I et al, Staging of Alzheimer-type pathology (2008)](https://pubmed.ncbi.nlm.nih.gov/18331440/)

[Braak H et al, Neuropathological staging of Alzheimer-related changes (2006)](https://pubmed.ncbi.nlm.nih.gov/16545497/)

[Walker LC et al, Alzheimer disease: one disease or many? (2015)](https://pubmed.ncbi.nlm.nih.gov/26192641/)

[Nelson PT et al, Correlation of Alzheimer disease neuropathologic changes with cognitive status (2012)](https://pubmed.ncbi.nlm.nih.gov/22403040/)

[Bennett DA et al, Neuropathology of older persons without cognitive impairment (2006)](https://pubmed.ncbi.nlm.nih.gov/16641938/)

[Jagust WJ et al, PET imaging of amyloid in the brain (2013)](https://pubmed.ncbi.nlm.nih.gov/24014567/)

[Jack CR et al, Hypothetical model of dynamic biomarkers of Alzheimer's disease (2013)](https://pubmed.ncbi.nlm.nih.gov/23558441/)

[Sperling RA et al, Toward defining the preclinical stages of Alzheimer's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21304398/)

[Albert MS et al, The diagnosis of mild cognitive impairment (2011)](https://pubmed.ncbi.nlm.nih.gov/21304400/)

[McKhann GM et al, Clinical diagnosis of Alzheimer's disease (2011)](https://pubmed.ncbi.nlm.nih.gov/21304401/)

[Knopman DS et al, Neuropathology of dementia (2021)](https://pubmed.ncbi.nlm.nih.gov/33784452/)

[Robinson JL et al, Neurodegenerative disease (2021)](https://pubmed.ncbi.nlm.nih.gov/34545678/)

📖 View canonical wiki page →

Related Entities

institutions-harvard-brain-tissue-resource-center

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-harvard-brain-tissue-resource-center
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-51399d88f29d
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-harvard-brain-tissue-resource-center'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

24

Outgoing

25

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Harvard Brain Tissue Resource Center

Overview

Overview

Mission

Collection Focus

Neurodegenerative Disease Collection

Research Contributions

Notable Discoveries

Collection Protocols

Brain Retrieval

Quality Assurance

Access Procedures

Application Requirements

Collaborations and Partnerships

Training Programs

Statistics and Impact

Governance and Funding

Quality Metrics

Sample Types Available

Future Directions

See Also

External Links

References

💬 Discussion